$SMMT
Summit Therapeutics Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$17.70
▲+4.12%+$0.700
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateSummit Therapeutics Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is SMMT up today? It is at $17.70 (+4.12%), and our scanner flagged it 328 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment SMMT spikes, and full due diligence on SMMT — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $SMMT 328 times in the last 30 days. Create a free account to track $SMMT, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on SMMT from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for SMMT today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystOther Material Event, from the latest SEC filing. Read it →The company can keep selling new shares into the market. Size not stated in the filing.
Some filings did not state a size, so these are floors.
At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing)
25,780,190 new shares · At-the-market (ATM) program — sells new shares into the market gradually over time · About $380.0M in size · Priced at $14.74/share
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Duggan Robert W Officer | Bought (open market) | +3.81M 0.5% of company | added 0.7% | 573.88M | $50.0M at $13.12 | Jun 12, 26 |
Zanganeh Mahkam Officer | Bought (open market) | +3.81M 0.5% of company | added 0.6% | 609.98M | $50.0M at $13.12 | Jun 12, 26 |
Soni Manmeet Singh Officer | Bought (open market) | +50K | added 1.6% | 3.12M | $722K at $14.43 | Jun 4, 26 |
Zanganeh Mahkam Officer | Bought (open market) | +100K 0.01% of company | added <0.1% | 606.17M | $1.5M at $14.60 | Jun 4, 26 |
Duggan Robert W Officer | Bought (open market) | +100K 0.01% of company | added 0.3% | 36.13M | $1.5M at $14.60 | Jun 4, 26 |
Zanganeh Mahkam Officer | Bought (open market) | +27K | added 53% | 77K | $500K at $18.74 | Oct 21, 25 |
Zanganeh Mahkam Officer | Acquired (grant/award) | +14.25M 1.8% of company | added 2.4% | 606.07M | $267.0M at $18.74 | Oct 21, 25 |
Duggan Robert W Officer | Acquired (grant/award) | +13.98M 1.8% of company | added 2.5% | 570.07M | $262.0M at $18.74 | Oct 21, 25 |
Duggan Robert W Officer | Acquired (grant/award) | +267K 0.03% of company | added 1.0% | 25.72M | $5.0M at $18.74 | Oct 21, 25 |
Duggan Robert W Officer | Bought (open market) | +27K | added <0.1% | 36.03M | $500K at $18.74 | Oct 21, 25 |
Soni Manmeet Singh Officer | Acquired (grant/award) | +53K | added 1.8% | 3.07M | $1000K at $18.74 | Oct 21, 25 |
Anand Bhaskar Officer | Acquired (grant/award) | +27K | added 20% | 160K | $500K at $18.74 | Oct 21, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on SMMT from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for SMMT today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
SMMT last traded at $17.70, up 4.12% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Summit Therapeutics Inc. Common Stock (SMMT) is next expected to report earnings on Monday, October 19, 2026, about 36 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The SMMT Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged SMMT 328 times in the last 30 days.
SMMT (Summit Therapeutics Inc. Common Stock) trades on XNAS, with a market cap of about $14.00B in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge SMMT for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$SMMT discussion
Sign in to ask a question or join the discussion.